Epinephrine Dose: Optimal Versus Standard Evaluation Trial

Status Recruiting

Clinical Trial Summary

The objective of this randomized controlled trial is to evaluate the effectiveness of a low cumulative dose of epinephrine compared to a standard cumulative dose of epinephrine during resuscitation from ventricular fibrillation (VF) or ventricular tachycardia (VT) in adult out-of-hospital cardiac arrest (OHCA) patients.

Clinical Trial Description

This study is designed as a prospective, multicentre, single-blinded randomized controlled trial (RCT) where eligible OHCA patients are randomized to receive a low cumulative dose of epinephrine (low dose epinephrine, up to 2mg total) or a standard cumulative dose of epinephrine (standard dose epinephrine, up to 6mg total) in a 1:1 fashion. Eligible OHCA patients will be treated by emergency medical service (EMS) providers who will initiate cardiopulmonary resuscitation (CPR) and the delivery of defibrillation shocks per EMS treatment protocols. After one defibrillation and when feasible, EMS providers will establish peripheral intravenous (IV) access, and patients will be randomly allocated to 1 of the 2 study arms. Subsequent study drug doses will be administered every 3-5 minutes, based on current guidelines and paramedic protocols, during resuscitation until the first return of spontaneous circulation (ROSC) is achieved or if resuscitation has been terminated by the base hospital physician. Other medications (e.g. antiarrhythmics, magnesium, beta blockers) and interventions (e.g. intubation) may be interposed as required. Follow-up will take place using a combination of administrative databases (e.g. the Discharge Abstract Database and the National Ambulatory Care Reporting System) and telephone interviews. This RCT will evaluate a fundamental change in the treatment of OHCA. The investigators hypothesize that a low cumulative dose of epinephrine will improve patient survival to hospital discharge compared to a standard cumulative dose of epinephrine. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT03826524
Study type	Interventional
Source	Unity Health Toronto
Contact	Theresa Aves, MSc
Phone	416-864-6060
Email	theresa.aves@unityhealth.to
Status	Recruiting
Phase	Phase 4
Start date	May 24, 2023
Completion date	June 2028

View Details

See also
Status	Clinical Trial	Phase
Recruiting	`NCT05654272` - Development of CIRC Technologies
Completed	`NCT05791032` - Sub Chronic Evaluation for ATP With an Extravascular Placed ICD Lead (STEP ICD) Study	N/A
Completed	`NCT04011631` - Evaluation of the iD-SystemTM, One-Handed Disposable Internal Defibrillation System.	N/A
Active, not recruiting	`NCT03700125` - Pre-hospital ECMO in Advanced Resuscitation in Patients With Refractory Cardiac Arrest. ( SUB30 )	N/A
Not yet recruiting	`NCT05325385` - Ventricular Fibrillation Following Out-of-hospital Cardiac Arrest
Completed	`NCT00241800` - Medications and the Risk of Sudden Cardiac Death	N/A
Completed	`NCT00139542` - AED Use in Out-of-Hospital Cardiac Arrest: A New Algorithm Named "One Shock Per Minute"	Phase 3
Completed	`NCT00119847` - Electrophysiological Effects of Late PCI After MI	N/A
Completed	`NCT00004560` - Public Access Defibrillation (PAD) Community Trial	Phase 3
Completed	`NCT00000531` - Antiarrhythmics Versus Implantable Defibrillators (AVID)	Phase 3
Completed	`NCT00000502` - Evaluation of SC-V Versus Conventional CPR	Phase 3
Completed	`NCT00000492` - Beta-Blocker Heart Attack Trial (BHAT)	Phase 3
Completed	`NCT04080986` - DOuble SEquential External Defibrillation for Refractory VF	N/A
Completed	`NCT01789554` - The Use of Mobile Phones in Out of Hospital Cardiac Arrest to Increase Bystander CPR	N/A
Completed	`NCT01940081` - The Leiden Nonischemic Cardiomyopathy Study
Completed	`NCT01089634` - Left Ventricular Capture Management Study
Completed	`NCT00382928` - Automatic External Defibrillation Monitoring in Cardiac Arrest	Phase 1
Completed	`NCT01161589` - First Arrhythmia Collection of Transvenous and Simultaneous Subcutaneous Implantable Defibrillator Data	N/A
Terminated	`NCT00776087` - European Health Economic Trial on Home Monitoring in ICD and CRT-D Patients (EuroEco)	N/A
Recruiting	`NCT04576130` - A Danish ICD-study in Patients With Coronary Artery Disease Resuscitated From Ventricular Fibrillation	N/A

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

Epinephrine Dose: Optimal Versus Standard Evaluation Trial — EpiDOSE

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms